Brolaconazole
- Level
- Commodity
- Parent
- 51302300
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51302304This classification denotes an antifungal agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 6CHG505391. European Medicines Agency schedules Brolaconazole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05902MIG. Brolaconazole generally arises in the molecular formula C17H15BRN2. The term BROLACONAZOLE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 2, no. 3, 1988, list 28.) BROLACONAZOLE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule brolaconazole under HS 29332990 and SITC 51573. As of Q4 2014, BROLACONAZOLE remains the US FDA Preferred Term for this commodity. Brolaconazole bears US NLM identifiers UMLS ID C2347212 and NCI Concept Code C72957. SMILES: BRC1CCC(C(CN2CCNC2)C2CCCCC2)CC1.
Same parent
Under 51302300 · 42Activities that produce or sell this
KBLI · 9Inherited from family 51300000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.